@thesis{thesis,
		author={Titik  Asliyani Murwati},
		title ={GAMBARAN PENGGUNAAN HEPATOPROTEKTOR
PADA PASIEN TUBERKULOSIS DEWASA
DI RSUD KABUPATEN KARANGANYAR
TAHUN 2018},
		year={2020},
		url={http://librepo.stikesnas.ac.id/447/},
		abstract={The liver is a very important organ in regulating the body's hemoestasis
including metabolism, biotransformation, synthesis, storage and immunology. The
cause of liver damage is the long-term use of drugs called hepatotoxicity. The use
of anti-tuberculosis drugs (OAT) in the treatment of tuberculosis is one of the
causes of hepatotoxicity. The purpose of this study was to determine the
description of the use of hepatoprotector in adult tuberculosis patients in
Karanganyar District Hospital. The method used in this research is nonexperimental descriptive. Data collection was carried out retrospectively through
medical records of adult Tuberculosis patients. Samples were obtained as many as
51 adult Tuberculosis patients who met the inclusion criteria by using purposive
sampling technique. The results of this study indicate the majority of adult male
Tuberculosis patients (51%). The use of hepatoprotector for adult Tuberculosis
patients in Karanganyar District Hospital of 51 patients who received
hepatoprotector 84.31% consisted of single drug 65.12% and combination drug
34.88%. A single hepatoprotector includes proliver 17.86%, Kurkumex 82.14%.
The use of hepatoprotector combination of liver aminophucine with curcumex
26.66%, liver aminofucin with proliver 66.67%, liver aminophucine with proliver
and curcumex 6.67%.}
		}